scholarly journals Quantifying the Costs to Different Funders over Five-Years for Women Diagnosed with Breast Cancer in Queensland, Australia: A Data Linkage Study

Author(s):  
Daniel Lindsay ◽  
Emily Callander

Individuals diagnosed with breast cancer have the highest rates of survival among all cancer types. Due to high survival, the costs of breast cancer to different healthcare funders are of interest. This study aimed to describe the cost to public hospital and private health funders and individuals due to hospital and emergency department (ED) admissions, as well Medicare items and pharmaceuticals over five years for Queensland women with breast cancer. We used a linked administrative dataset, CancerCostMod, limited to Queensland female breast cancer diagnoses between July 2011 and June 2013 aged 18 years or over who survived for 5 years (n = 5383). Each record was linked to Queensland Health Admitted Patient Data Collection, Emergency Department Information Systems, Medicare Benefits Schedule, and Pharmaceutical Benefits Scheme records between July 2011 and June 2018. Total costs for different healthcare funders as a result of breast cancer diagnoses were reported, with high costs and service use identified in the first six months following a breast cancer diagnosis. After the first six months post-diagnosis, the financial burdens incurred by different healthcare funders for breast cancer diagnoses in Queensland remain steady over a long period. Recommendations for reducing long term costs are discussed.

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Catharina Bartmann ◽  
Leah-Maria Fischer ◽  
Theresa Hübner ◽  
Max Müller-Reiter ◽  
Achim Wöckel ◽  
...  

Abstract Background The majority of breast cancer patients are severely psychologically affected by breast cancer diagnosis and subsequent therapeutic procedures. The COVID-19 pandemic and associated restrictions on public life have additionally caused significant psychological distress for much of the population. It is therefore plausible that breast cancer patients might be particularly susceptible to the additional psychological stress caused by the pandemic, increasing suffering. In this study we therefore aimed to assess the level of psychological distress currently experienced by a defined group of breast cancer patients in our breast cancer centre, compared to distress levels pre-COVID-19 pandemic. Methods Female breast cancer patients of all ages receiving either adjuvant, neoadjuvant, or palliative therapies were recruited for the study. All patients were screened for current or previous COVID-19 infection. The participants completed a self-designed COVID-19 pandemic questionnaire, the Stress and Coping Inventory (SCI), the National Comprehensive Cancer Network® (NCCN®) Distress Thermometer (DT), the European Organization for Research and Treatment of Cancer (EORTC) QLQ C30, and the BR23. Results Eighty-two breast cancer patients were included. Therapy status and social demographic factors did not have a significant effect on the distress caused by the COVID-19 pandemic. The results of the DT pre and during COVID-19 pandemic did not differ significantly. Using the self-designed COVID-19 pandemic questionnaire, we detected three distinct subgroups demonstrating different levels of concerns in relation to SARS-CoV-2. The subgroup with the highest levels of concern reported significantly decreased life quality, related parameters and symptoms. Conclusions This monocentric study demonstrated that the COVID-19 pandemic significantly affected psychological health in a subpopulation of breast cancer patients. The application of a self-created “COVID-19 pandemic questionnaire” could potentially be used to help identify breast cancer patients who are susceptible to increased psychological distress due to the COVID-19 pandemic, and therefore may need additional intensive psychological support. Trial registration DRKS-ID: DRKS00022507.


BMJ Open ◽  
2020 ◽  
Vol 10 (10) ◽  
pp. e036341
Author(s):  
Shao-Yi Huang ◽  
Ho-Min Chen ◽  
Kai-Hsin Liao ◽  
Bor-Sheng Ko ◽  
Fei-Yuan Hsiao

ObjectiveCancers result in significant economic burdens on patients, health sectors and society. Reliable burden estimates will help guide resource allocation. This study aimed to perform a nationwide cost analysis of the direct and indirect costs of the top ten most costly cancers, and acute coronary syndrome (ACS), as a comparison, in Taiwan.SettingA population-based cohort study.ParticipantsIn total, 545 221 patients with newly diagnosed cancer (lung cancer, female breast cancer, colorectal cancer, liver cancer, oral cancer, leukaemia, prostate cancer, non-Hodgkin's lymphoma, gastric cancer and oesophageal cancer) and 170 879 patients with ACS between 2007 and 2014 were identified.Primary and secondary outcome measuresDirect medical costs were calculated from claims recorded in the National Health Insurance Research Database . Indirect costs, comprising morbidity-associated and mortality-associated productivity losses, were estimated from public life expectancy, average wage and employment data. The costs incurred in the 3 years after diagnosis were assessed. As a comparison, the cost of ACS was also estimated using the same study frame. A cost driver analysis was conducted to identify factors impacting cancer costs.ResultsThe cancers with the highest mean direct medical costs and total costs were leukaemia (US$28 464) and oesophageal cancer (US$81 775), respectively. Indirect costs accounted for over 50% of the total economic burden of most cancers, except for prostate cancer and female breast cancer. The costs of ACS were lower than those of most cancers. From the cost driver analysis, older age at diagnosis significantly (p<0.05) decreased the total cost of cancer; in contrast, male, tumour metastasis, comorbidities and treatment in medical centres increased the costs.ConclusionsThis study demonstrates the comprehensive economic burden of the top 10 most costly cancers in Taiwan. These results are valuable for optimising healthcare resource allocation.


2020 ◽  
Author(s):  
Sulleh Gbande ◽  
Lillian Ohene ◽  
Lydia Aziato

Abstract Background: Chemotherapy is the most common treatment option for breast cancer in Ghana. Chemotherapy brings about unpleasant and traumatic experiences due to the effects of drugs on patients. Despite contexts specific variations, recent literature show improvement in breast cancer survival rates globally. Methods: This study aimed to explore factors that influenced resilience among women who completed chemotherapy for breast cancer in the Greater Accra Metropolis of Ghana. A qualitative exploratory descriptive design was adopted to study fifteen breast cancer survivors. A purposive sampling technique was used to select the participants. Individual in-depth interviews were conducted in English using a semi-structured interview guide. Data collection and analysis occurred concurrently. All interviews were audio-recorded with consent from the participants. Using a thematic and content analysis approach, all interviews were transcribed verbatim, coded and themes and subthemes generated. Results: Two major themes and eight subthemes were generated. Thus, 1. The Burden associated with breast cancer diagnosis and treatment; with subthemes; Physical, Psychological, Social, Financial burdens. 2. Personal traits; and the subthemes; Hope, Optimism, Self-esteem, Confidence.Conclusions: The study concluded that chemotherapy is associated with biopsychosocial pain and economic burden. In the absence of organized support systems, surviving breast cancer treatment is influenced by individuals’ personality and emotional orientation to the disease.


2022 ◽  
Vol 22 (1) ◽  
Author(s):  
Tran Thu Ngan ◽  
Nguyen Bao Ngoc ◽  
Hoang Van Minh ◽  
Michael Donnelly ◽  
Ciaran O’Neill

Abstract Background There is a paucity of research on the cost of breast cancer (BC) treatment from the patient’s perspective in Vietnam. Methods Individual-level data about out-of-pocket (OOP) expenditures on use of services were collected from women treated for BC (n = 202) using an online survey and a face-to-face interview at two tertiary hospitals in 2019. Total expenditures on diagnosis and initial BC treatment were presented in terms of the mean, standard deviation, and range for each type of service use. A generalised linear model (GLM) was used to assess the relationship between total cost and socio-demographic characteristics. Results 19.3% of respondents had stage 0/I BC, 68.8% had stage II, 9.4% had stage III, none had stage IV. The most expensive OOP elements were targeted therapy with mean cost equal to 649.5 million VND ($28,025) and chemotherapy at 36.5 million VND ($1575). Mean total OOP cost related to diagnosis and initial BC treatment (excluding targeted therapy cost) was 61.8 million VND ($2667). The mean OOP costs among patients with stage II and III BC were, respectively, 66 and 148% higher than stage 0/I. Conclusions BC patients in Vietnam incur significant OOP costs. The cost of BC treatment was driven by the use of therapies and presentation stage at diagnosis. It is likely that OOP costs of BC patients would be reduced by earlier detection through raised awareness and screening programmes and by providing a higher insurance reimbursement rate for targeted therapy.


2015 ◽  
Author(s):  
Faustine Williams ◽  
Stephen Jeanetta ◽  
David O'Brien ◽  
John Fresen

2021 ◽  
Author(s):  
Tran Ngan ◽  
Nguyen Ngoc ◽  
Hoang Minh ◽  
Michael Donnelly ◽  
Ciaran O'Neill

Abstract Background: There is a paucity of research on the cost of breast cancer (BC) treatment from the patient’s perspective in Vietnam.Methods: Individual-level data about out-of-pocket (OOP) expenditures on use of services were collected from women treated for BC (n=202) using an online survey and a face-to-face interview at two tertiary hospitals in 2019. Total expenditures on diagnosis and initial BC treatment were presented in terms of the mean, standard deviation, and range for each type of service use. A generalised linear model (GLM) was used to assess the relationship between total cost and socio-demographic characteristics.Results: 19.3% of respondents had stage 0/I BC, 68.8% had stage II, 9.4% had stage III, none had stage IV. The most expensive OOP elements were targeted therapy with mean cost equal to 649.5 million VND ($28,025) and chemotherapy at 36.5 million VND ($1,575). Mean total OOP cost related to diagnosis and initial BC treatment (excluding targeted therapy cost) was 61.8 million VND ($2,667). The mean OOP costs among patients with stage II and III BC were, respectively, 66% and 148% higher than stage I.Conclusions: BC patients in Vietnam incur significant OOP costs. The cost of BC treatment was driven by use of therapies and presentation stage at diagnosis. It is likely that OOP costs of BC patients would be reduced by earlier detection through raised awareness and screening programs and by providing a higher insurance coverage rate for targeted therapy.


BMJ Open ◽  
2018 ◽  
Vol 8 (2) ◽  
pp. e018613 ◽  
Author(s):  
Xue Li ◽  
Preeyaporn Srasuebkul ◽  
Simone Reppermund ◽  
Julian Trollor

ObjectiveTo use linked administrative datasets to assess factors associated with emergency department (ED) presentation and psychiatric readmission in three distinctive time intervals after the index psychiatric admission.DesignA retrospective data-linkage study.SettingCohort study using four linked government minimum datasets including acute hospital care from July 2005 to June 2012 in New South Wales, Australia.ParticipantsPeople who were alive and aged ≥18 years on 1 July 2005 and who had their index admission to a psychiatric ward from 1 July 2007 to 30 June 2010.Outcome measuresORs of factors associated with psychiatric admission and ED presentation were calculated for three intervals: 0–1 month, 2–5 months and 6–24 months after index separation.ResultsIndex admission was identified in 35 056 individuals (51% -males) with a median age of 42 years. A total of 12 826 (37%) individuals had at least one ED presentation in the 24 months after index admission. Of those, 3608 (28%) presented within 0–1 month, 6350 (50%) within 2–5 months and 10 294 (80%) within 6–24 months after index admission. A total of 14 153 (40%) individuals had at least one psychiatric readmission in the first 24 months. Of those, 6808 (48%) were admitted within 0–1 month, 6433 (45%) within 2–5 months and 7649 (54%) within 6–24 months after index admission. Principal diagnoses and length of stay at index admission, sociodemographic factors, Charlson Comorbidity Index score, drug and alcohol comorbidity, intellectual disability and other inpatient service use were significantly associated with ED presentations and psychiatric readmissions, and these relationships varied somewhat over the intervals studied.ConclusionSocial determinants of service use, drug and alcohol intervention, addressing needs of individuals with intellectual disability and recovery-oriented whole-person approaches at index admission are key areas for investment to improve trajectories after index admission.


2020 ◽  
Vol 26 (2) ◽  
pp. 120-135
Author(s):  
Katharine Woodhouse ◽  
Julia Yates

AbstractThis article reports on women’s experiences of career change following a breast cancer diagnosis and explores whether their illness represents the driving force to pursue previously unfulfilled career ambitions. The participants were four women who had been diagnosed with breast cancer and had changed career direction after their treatment. Data were conducted through in-depth interviews and were analyzed using Interpretative Phenomenological Analysis (IPA). Four themes prominent throughout each women’s narrative were identified: (i) a pre-diagnosis, unhappiness at work, (ii) a sense of stepping off the treadmill, (iii) a sharp focus upon their “self,” and subsequently (iv) a flourishing “work-life.” Further research is needed to investigate how common these findings are among women with breast cancer.


2014 ◽  
Vol 2 (2) ◽  
pp. 344-349
Author(s):  
Nurka Pranjić ◽  
Ibrahim Gledo ◽  
Ljiljana Maleš-Bilić

BACKGROUND: Numerous studies have observed risk factors for breast cancer. We aimed to investigate and assess the relationship between individual, social, occupational and environmental determinants of breast cancer using a questionnaire among 100 newly diagnosed female breast cancer patients and 100 control female subjects without cancer.METHODS: A case-control study using a family ambulatory based survey was conducted among 200 female patients from all municipalities of Zenica - Doboj Canton. New cases of breast cancer among subjects of experimental group (n = 100) were diagnosed between January 1, 2003 and December 31, 2007 using the institutional clinical procedure for breast cancer diagnosis. Data were obtained using a self - rated questionnaire specially designed for this research. The questionnaire contains a group of questions about individual and demographic data, occupational and environment characteristics, reproductive hystory, body mass index, life style and quality life factors.RESULTS: Fifty two percent of our examinees with breast cancer are housewives. There were no significant differences between the two groups and their subgroups except for prevalence of routine physical activity (P = 0.016), unemployment (P = 0.004), history arrival menopause (P = 0.012), and type of occupation/ workplace (P = 0.015) among subjects with breast cancer in relation to control subjects. We found significantly higher prevalence for failure to routine physical activity (P = 0.006), obesity (P = 0.009), unemployment (P = 0.001), unsecure existence (P = 0.015), and low level of education (P = 0.001) in housewives in relationship to others occupation.CONCLUSION: The most common new cases of breast cancer were among housewife. Inverse significantly link between breast cancer and poverty, arrival time of menopause and distant-cousin- degree family history were found. For most women, physical activity may reduce the risk of invasive breast cancer.


Sign in / Sign up

Export Citation Format

Share Document